United States · Bill · S
S. 2895 (116th)
SARMs Control Act of 2019
Introduced
19 November 2019
Last action
19 November 2019 · Introduced
Status
Read twice and referred to the Committee on the Judiciary.
Sponsors
Chuck Grassley, Sheldon Whitehouse
Subjects
Discovery layer
Source updated
10 August 2026
Summary
Selective Androgen Receptor Modulators Control Act of 2019 or the SARMs Control Act of 2019 This bill expands the federal regulatory framework for drugs that are deemed to pose a risk of abuse and dependence to address selective androgen receptor modulators. These are synthetic drugs or substances that have effects similar to testosterone.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
19 November 2019
Introduced
Read twice and referred to the Committee on the Judiciary.
Source: IntroReferral
19 November 2019
Introduced
Introduced in Senate
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 19 November 2019 · Official file
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 19 November 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 19 November 2019
Introduced in Senate
summary · EN · 19 November 2019
Sponsors
- Chuck Grassley · R · Sponsor
- Sheldon Whitehouse · D · Sponsor
- · ssju00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/2895
- Open data entity: https://api.congress.gov/v3/bill/116/s/2895
- us · 116-s-2895 · source updated 10 August 2026